# Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia

> **NCT00491296** · — · UNKNOWN · sponsor: **HaEmek Medical Center, Israel**

## Conditions studied

- Bladder Cancer

## Interventions

- **DEVICE:** SYNERGO
- **DEVICE:** SYNERGO-intravesical chemotherapy instillation combined with hyperthermia

## Key facts

- **NCT ID:** NCT00491296
- **Lead sponsor:** HaEmek Medical Center, Israel
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** — (—)
- **Last updated:** 2008-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491296, "Changes in Prostate Specific Antigen Levels During Synergo Therapy-Intravesical Chemotherapy Instillations Combined With Hyperthermia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00491296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*